loading
前日終値:
$4.26
開ける:
$4.29
24時間の取引高:
8,122
Relative Volume:
0.05
時価総額:
$90.17M
収益:
-
当期純損益:
$-102.09M
株価収益率:
-4.1857
EPS:
-1.05
ネットキャッシュフロー:
$-108.72M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-2.77%
6か月 パフォーマンス:
-5.31%
1年 パフォーマンス:
-45.75%
1日の値動き範囲:
Value
$4.1633
$4.60
1週間の範囲:
Value
$4.1633
$4.60
52週間の値動き範囲:
Value
$2.2045
$9.09

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
名前
Dbv Technologies Adr
Name
セクター
Healthcare (1169)
Name
電話
33(0)155427878
Name
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
職員
108
Name
次回の収益日
2024-07-29
Name
最新のSEC提出書
Name
DBVT's Discussions on Twitter

DBVT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DBVT
Dbv Technologies Adr
4.395 90.17M 0 -102.09M -108.72M -1.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-01-04 アップグレード Societe Generale Hold → Buy
2022-12-16 ダウングレード Goldman Neutral → Sell
2022-05-10 ダウングレード Goldman Buy → Neutral
2021-09-14 アップグレード Societe Generale Hold → Buy
2021-01-22 ダウングレード Societe Generale Hold → Sell
2020-11-02 アップグレード Societe Generale Sell → Hold
2020-08-06 ダウングレード Societe Generale Buy → Sell
2020-08-05 繰り返されました H.C. Wainwright Buy
2020-03-17 ダウングレード Stifel Buy → Hold
2020-01-09 アップグレード Stifel Hold → Buy
2019-12-16 開始されました Citigroup Buy
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-06-17 開始されました Goldman Buy
2018-12-20 ダウングレード Barclays Overweight → Equal Weight
2018-12-20 ダウングレード BofA/Merrill Buy → Underperform
2018-12-20 ダウングレード Jefferies Buy → Hold
2018-12-20 ダウングレード Stifel Buy → Hold
2017-10-31 アップグレード Societe Generale Sell → Hold
2017-10-24 ダウングレード Societe Generale Buy → Sell
2017-10-23 ダウングレード Morgan Stanley Overweight → Equal-Weight
2017-06-23 開始されました Deutsche Bank Buy
2017-03-16 アップグレード Societe Generale Hold → Buy
2016-09-26 開始されました JMP Securities Mkt Outperform
2015-12-03 開始されました Barclays Overweight
2015-10-23 開始されました BofA/Merrill Buy
すべてを表示

Dbv Technologies Adr (DBVT) 最新ニュース

pulisher
Feb 21, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading - MSN

Feb 21, 2025
pulisher
Feb 20, 2025

DBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.com - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

DBV Technologies (NASDAQ:DBVT) Stock Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - TradingView

Feb 19, 2025
pulisher
Feb 18, 2025

DBV Technologies stock holds firm with $10 target from JMP By Investing.com - Investing.com South Africa

Feb 18, 2025
pulisher
Feb 18, 2025

DBV Technologies stock holds firm with $10 target from JMP - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

DBV Technologies (NASDAQ:DBVT) Shares Cross Above Fifty Day Moving Average – Time to Sell? - Defense World

Feb 18, 2025
pulisher
Feb 14, 2025

DBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.com - MarketBeat

Feb 14, 2025
pulisher
Feb 11, 2025

DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN

Feb 10, 2025
pulisher
Feb 10, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - MSN

Feb 10, 2025
pulisher
Feb 07, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView

Feb 07, 2025
pulisher
Feb 05, 2025

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading - TradingView

Feb 05, 2025
pulisher
Jan 28, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading - MSN

Jan 28, 2025
pulisher
Jan 25, 2025

DBV Technologies (NASDAQ:DBVT) Shares Cross Above 50-Day Moving AverageShould You Sell? - MarketBeat

Jan 25, 2025
pulisher
Jan 25, 2025

StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World

Jan 25, 2025
pulisher
Jan 21, 2025

Patch effective through 36 months in treating toddlers with peanut allergy - Healio

Jan 21, 2025
pulisher
Jan 17, 2025

DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 17, 2025
pulisher
Jan 14, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN

Jan 14, 2025
pulisher
Jan 13, 2025

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - MSN

Jan 13, 2025
pulisher
Jan 13, 2025

DBV Technologies Reports H2 2024 Liquidity Contract Results: 440,957 Shares Traded - StockTitan

Jan 13, 2025
pulisher
Jan 12, 2025

JMP Securities Reiterates “Market Outperform” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

DBV Technologies' SWOT analysis: peanut allergy patch maker's stock faces pivotal year By Investing.com - Investing.com South Africa

Jan 11, 2025
pulisher
Jan 11, 2025

DBV Technologies' SWOT analysis: peanut allergy patch maker's stock faces pivotal year - Investing.com India

Jan 11, 2025
pulisher
Jan 10, 2025

DBV Technologies' (DBVT) Market Outperform Rating Reiterated at JMP Securities - MarketBeat

Jan 10, 2025
pulisher
Jan 09, 2025

StockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

DBV Technologies Reports Positive Phase 3 Study Results - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

DBV Technologies announces three-year results from EPITOPE trial - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

DBV's VIASKIN Peanut Patch Shows Breakthrough 83.5% Success Rate in Toddler Study - StockTitan

Jan 08, 2025
pulisher
Jan 04, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Flat for Week - MSN

Jan 04, 2025
pulisher
Jan 01, 2025

DBV Technologies (NASDAQ:DBVT) Share Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat

Jan 01, 2025
pulisher
Dec 29, 2024

European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN

Dec 29, 2024
pulisher
Dec 29, 2024

European Equities Traded in the US as American Depositary Rise in Thursday Trading - MSN

Dec 29, 2024
pulisher
Dec 28, 2024

European Equities Traded in the US as American Depositary Edge Lower in Thursday Trading - MSN

Dec 28, 2024
pulisher
Dec 28, 2024

European Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for Week - MSN

Dec 28, 2024

Dbv Technologies Adr (DBVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Dbv Technologies Adr (DBVT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Mohideen Pharis
Chief Medical Officer
Nov 25 '24
Sale
0.57
565
322
111,110
Mohideen Pharis
Chief Medical Officer
Nov 22 '24
Sale
0.53
342
181
111,675
Mohideen Pharis
Chief Medical Officer
Nov 21 '24
Sale
0.54
2,350
1,269
112,017
Mohideen Pharis
Chief Medical Officer
Jul 29 '24
Sale
0.98
1,785
1,749
79,367
Mohideen Pharis
Chief Medical Officer
May 24 '24
Sale
1.36
660
898
81,152
Mohideen Pharis
Chief Medical Officer
May 22 '24
Sale
1.38
382
527
81,812
Tasse Daniel
CHIEF EXECUTIVE OFFICER
Mar 08 '24
Buy
0.83
17,094
14,188
17,094
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):